These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2157836)

  • 1. Effects of zidovudine on Friend virus complex infection in Rfv-3r/s genotype-containing mice used as a model for HIV infection.
    Morrey JD; Warren RP; Okleberry KM; Burger RA; Johnston MI; Sidwell RW
    J Acquir Immune Defic Syndr (1988); 1990; 3(5):500-10. PubMed ID: 2157836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of murine retroviral disease by 2',3'-didehydro-2',3'-dideoxythymidine (D4T).
    Sidwell RW; Hitchcock M; Okleberry KM; Burger RA; Warren RP; Morrey JD
    Antiviral Res; 1992 Oct; 19(4):313-24. PubMed ID: 1334395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early-initiated zidovudine therapy prevents disease but not low levels of persistent retrovirus in mice.
    Morrey JD; Okleberry KM; Sidwell RW
    J Acquir Immune Defic Syndr (1988); 1991; 4(5):506-12. PubMed ID: 2016687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of imexon treatment on Friend virus complex infection using genetically defined mice as a model for HIV-1 infection.
    Morrey JD; Warren RP; Okleberry KM; Burger RA; Chirigos MA; Sidwell RW
    Antiviral Res; 1991 Jan; 15(1):51-65. PubMed ID: 2036000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement for CD4(+) T cells in the Friend murine retrovirus neutralizing antibody response: evidence for functional T cells in genetic low-recovery mice.
    Super HJ; Brooks D; Hasenkrug K; Chesebro B
    J Virol; 1998 Nov; 72(11):9400-3. PubMed ID: 9765497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidation of mode of retroviral-inhibitory effects of imexon through use of immune competent and severe combined immune deficiency (SCID) mice.
    Morrey JD; Mead JR; Warren RP; Okleberry KM; Burger RA; Sidwell RW
    Antiviral Res; 1992 Mar; 17(3):223-33. PubMed ID: 1314537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Friend virus antibody is associated with recovery from viremia and loss of viral leukemia cell-surface antigens in leukemic mice. Identification of Rfv-3 as a gene locus influencing antibody production.
    Doig D; Chesebro B
    J Exp Med; 1979 Jul; 150(1):10-9. PubMed ID: 286744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproliferative effect of D-aspartic acid beta-hydroxamate (DAH) on Friend virus-infected erythropoietic progenitor cells.
    Tournaire R; Arnaud S; Hamedi-Sangsari F; Malley S; Grange J; Blanchet JP; Doré JF; Vila J
    Leukemia; 1994 Oct; 8(10):1703-7. PubMed ID: 7934166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methionine enkephalin combined with AZT therapy reduce murine retrovirus-induced disease.
    Specter S; Plotnikoff N; Bradley WG; Goodfellow D
    Int J Immunopharmacol; 1994 Nov; 16(11):911-7. PubMed ID: 7868296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Filariae-Retrovirus Co-infection in Mice is Associated with Suppressed Virus-Specific IgG Immune Response and Higher Viral Loads.
    Dietze KK; Dittmer U; Koudaimi DK; Schimmer S; Reitz M; Breloer M; Hartmann W
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005170. PubMed ID: 27923052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine retroviral disease-enhancing effects of a pyrimidinone immunomodulator.
    Warren RP; Morrey JD; Burger RA; Okleberry KM; Sidwell RW
    Antiviral Res; 1992 Sep; 19(3):233-45. PubMed ID: 1444328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effects of diethylcarbamazine and 3'-azido-3'-deoxythymidine on feline leukemia virus lymphoma formation.
    Nelson P; Sellon R; Novotney C; Devera C; Davidian M; English R; Tompkins M; Tompkins W
    Vet Immunol Immunopathol; 1995 May; 46(1-2):181-94. PubMed ID: 7618257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow transplantation from Fv-4-resistant donors rescues Friend leukemia virus-infected mice from leukemia: a model of bone marrow transplantation therapy against retroviral infection.
    Kitagawa M; Kamisaku H; Aizawa S; Sado T
    Leukemia; 1994 Dec; 8(12):2200-6. PubMed ID: 7808008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of combination interleukin-3 (IL-3) and granulocyte-macrophage colony stimulating factor (GM-CSF) on hematopoiesis administered to retrovirus-infected immunodeficient mice receiving dose-escalation zidovudine (AZT).
    Gallicchio VS; Hughes NK; Tse KF; Ling J; Gaines H; Bowen TE; Uluitu M
    Int J Immunopharmacol; 1995 Nov; 17(11):865-78. PubMed ID: 8788116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular assessment of the potential combination therapy of cytokines with biphalin and AZT for Friend leukemia virus infection in vitro.
    Tang JL; Lipkowski AW; Specter S
    Pharmacol Rep; 2008; 60(2):190-8. PubMed ID: 18443380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of cytokine levels in murine retrovirus infection: modulation by combination therapy.
    Bowden R; Tate SM; Soto S; Specter S
    Int J Immunopharmacol; 1999 Dec; 21(12):815-27. PubMed ID: 10606002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing zidovudine efficacy when administered at early stages of Friend virus infection in mice.
    Sinet M; Desforges B; Launay O; Colin JN; Pocidalo JJ
    Antiviral Res; 1991 Sep; 16(2):163-71. PubMed ID: 1799277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major histocompatibility complex class I gene controls the generation of gamma interferon-producing CD4(+) and CD8(+) T cells important for recovery from friend retrovirus-induced leukemia.
    Peterson KE; Iwashiro M; Hasenkrug KJ; Chesebro B
    J Virol; 2000 Jun; 74(11):5363-7. PubMed ID: 10799615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of mice against Friend retrovirus infection by vaccination with antigen-loaded, spleen-derived dendritic cells.
    Reuter T; Heldmann M; Schimmer S; Schepers K; Dittmer U
    Vaccine; 2004 Jul; 22(21-22):2686-9. PubMed ID: 15246598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced provirus burden and enhanced humoral immune function in AZT-treated SCID-feline mice inoculated with feline immunodeficiency virus.
    Johnson CM; Selleseth DW; Ellis MN; Childers TA; Tompkins MB; Tompkins WA
    Vet Immunol Immunopathol; 1995 May; 46(1-2):169-80. PubMed ID: 7618256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.